The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Abroad (travel likely)RecruitingPHASE2
Conditions
Systemic Lupus Erythematosus (SLE) · Lupus Nephritis (LN)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Research Ethics Committee of the General Hospital of Eastern Theater Command of the People's Liberation Army, Nanjing, Jiangsu, China